Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Tenaya Therapeutics (TNYA) is now available.
Jin-Long Chen has voluntarily resigned from his position as a director at Tenaya Therapeutics, Inc., as well as from his role on the company’s Corporate Governance & Nominating Committee. His departure was amicable, with no disagreements reported with the Company or its Board of Directors.
For detailed information about TNYA stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges